Inactive Instrument
Aradigm Corporation Share Price Nasdaq
Stocks
US0385054004
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 48.85L 42.69L 39.4L 36.31L 68.44L 47Cr 69.96L 4.71Cr 1.85Cr 23Cr 1.83Cr 1.79Cr 79Cr | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.28Cr 1.12Cr 1.03Cr 95.13L 1.79Cr 123.25Cr 1.83Cr 12Cr 4.85Cr 60Cr 4.81Cr 4.7Cr 207.8Cr | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +36.88% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +36.88% | +25.50% | - | - | 7L | ||
| -0.53% | -3.91% | +0.71% | +2.39% | 4.92TCr | ||
| +0.20% | +1.89% | +387.83% | +598.83% | 3.96TCr | ||
| +0.82% | +4.00% | +8.29% | +63.89% | 3.47TCr | ||
| -1.09% | -1.95% | +28.03% | -10.10% | 3.44TCr | ||
| +0.06% | +0.34% | +2.38% | +34.47% | 2.71TCr | ||
| +0.25% | -0.74% | - | - | 1.62TCr | ||
| -0.04% | +0.91% | +73.21% | +116.69% | 1.54TCr | ||
| +0.31% | +1.44% | +14.49% | +17.27% | 1.41TCr | ||
| -2.03% | +2.64% | +22.09% | -31.09% | 1.3TCr | ||
| Average | +3.55% | +0.03% | +67.13% | +99.04% | 2.71TCr | |
| Weighted average by Cap. | -0.15% | -0.18% | +80.54% | +124.22% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 2L 2L 2L 1L 3L 1.88Cr 3L 18.8L 7L 91.97L 7L 7L 3.17Cr | 1.45Cr 1.26Cr 1.17Cr 1.08Cr 2.03Cr 139.3Cr 2.07Cr 14Cr 5.48Cr 68Cr 5.43Cr 5.31Cr 234.86Cr |
| Net income | -3.29Cr -2.88Cr -2.66Cr -2.45Cr -4.61Cr -317.2Cr -4.72Cr -32Cr -12Cr -155.35Cr -12Cr -12Cr -534.79Cr | -1.07Cr -93.55L -86.33L -79.57L -1.5Cr -103.09Cr -1.53Cr -10Cr -4.06Cr -50Cr -4.02Cr -3.93Cr -173.81Cr |
| Net Debt | -93.72L -81.9L -75.58L -69.66L -1.31Cr -90Cr -1.34Cr -9.03Cr -3.55Cr -44Cr -3.52Cr -3.44Cr -152.17Cr | 79.13L 69.15L 63.81L 58.82L 1.11Cr 76Cr 1.13Cr 7.63Cr 3Cr 37Cr 2.97Cr 2.91Cr 128.48Cr |
Employees
-
















